Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools.
Lang S, Farowski F, Martin A, Wisplinghoff H, Vehreschild MJGT, Krawczyk M, Nowag A, Kretzschmar A, Scholz C, Kasper P, Roderburg C, Lammert F, Goeser T, Steffen HM, Demir M. Lang S, et al. Among authors: farowski f. Sci Rep. 2020 Jun 10;10(1):9385. doi: 10.1038/s41598-020-66241-0. Sci Rep. 2020. PMID: 32523101 Free PMC article.
Mucormycosis treated with posaconazole: review of 96 case reports.
Vehreschild JJ, Birtel A, Vehreschild MJ, Liss B, Farowski F, Kochanek M, Sieniawski M, Steinbach A, Wahlers K, Fätkenheuer G, Cornely OA. Vehreschild JJ, et al. Among authors: farowski f. Crit Rev Microbiol. 2013 Aug;39(3):310-24. doi: 10.3109/1040841X.2012.711741. Epub 2012 Aug 24. Crit Rev Microbiol. 2013. PMID: 22917084 Review.
Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.
Würthwein G, Cornely OA, Trame MN, Vehreschild JJ, Vehreschild MJ, Farowski F, Müller C, Boos J, Hempel G, Hallek M, Groll AH. Würthwein G, et al. Among authors: farowski f. Antimicrob Agents Chemother. 2013 Apr;57(4):1664-71. doi: 10.1128/AAC.01912-12. Epub 2013 Jan 18. Antimicrob Agents Chemother. 2013. PMID: 23335740 Free PMC article. Clinical Trial.
First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe.
Tacke D, Wisplinghoff H, Kretzschmar A, Farowski F, Koehler P, Herweg J, Cornely OA, Vehreschild MJ. Tacke D, et al. Among authors: farowski f. Clin Microbiol Infect. 2015 Nov;21(11):e82-4. doi: 10.1016/j.cmi.2015.06.027. Epub 2015 Jul 8. Clin Microbiol Infect. 2015. PMID: 26163107 Free article. No abstract available.
Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection.
Farowski F, Solbach P, Tsakmaklis A, Brodesser S, Cruz Aguilar MR, Cornely OA, Dettmer K, Higgins PG, Suerbaum S, Jazmati N, Oefner PJ, Vehreschild MJGT; German Clinical Microbiome Study Group (GCMSG). Farowski F, et al. Dig Liver Dis. 2019 Jul;51(7):944-951. doi: 10.1016/j.dld.2019.01.012. Epub 2019 Jan 26. Dig Liver Dis. 2019. PMID: 30770201
42 results